Log In
BCIQ
Print this Print this
 

Hepa-Merz

  Manage Alerts
Collapse Summary General Information
Company Merz GmbH & Co. KGaA
DescriptionCombination of ornithine and aspartate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationLiver disease
Indication DetailsTreat hepatic encephalopathy (HE)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today